The pet diabetes care devices market is capturing a valuation of US$ 2.3 billion in 2023 and is expected to reach US$ 4.3 billion by 2033. The market is registering a CAGR of 6.2% during the forecast period.
The market is influenced by the rising pet population and increasing prevalence of diabetes among pets. The several factors that drive the global market are:
These factors are anticipated to boost the market share in the coming years.
Stringent Regulations and Limit Awareness Decline the Market Growth
The market has several restraining factors that may limit market growth are:
| Attributes | Details |
|---|---|
| Market CAGR (2023 to 2033) | 6.2% |
| Market Valuation (2023) | US$ 2.3 billion |
| Market Valuation (2033) | US$ 4.3 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market was valued at US$ 1.7 billion in 2018 and US$ 2.20 billion in 2022. The market secured a CAGR of 5.7% between 2018 and 2022. The market has grown moderately during this period through collaboration and product launches.
The market expanded through various factors such as pet illness, growing pet population, lack of proper meals, and lack of awareness. These essential factors increased the adoption of pet diabetes care devices. The increasing pet healthcare infrastructure and innovation on pet care devices sustain market growth.
Based on animal type, the dog category dominate the global market by securing a share of 48.0% during the forecast period. Dogs are commonly affected by diabetes, which uplifts the demand for pet diabetes care devices. Pet diabetes care devices are beneficial for managing pets' blood glucose and monitoring their health. A few of these devices are insulin pens and syringes.
Other animals, such as cats, rabbits, and horses, are also diagnosed with diabetes that require the same pet care devices. Overall, dogs are highly diagnosed with diabetes and are estimated to lead the global market by 2033. These devices determine accurate results related animal's age, glucose level, weight, and related health conditions.
Based on the device, insulin syringes are leading the global market by registering a share of 32.1% by 2033. Insulin syringes are highly adopted devices to treat pet diabetes around the globe. These insulin syringes are designed in various sizes and shapes to be easily used and deliver insulin doses to pets. The insulin syringes are made of plastic and glass, which are more comfortable and provide better experiences.
Insulin syringes are highly preferred over other devices, such as pumps and insulin pens, due to their lower maintenance cost. These insulin syringes are widely used for vaccinations, blood tests, and administering medications. It includes catheter syringes, safety syringes, and among others.
The demand for insulin syringes is increasing due to its aging demographics, growing population, and prevalence of diabetes and other chronic diseases. These factors play a key role in upsurging the adoption of insulin syringes.
Principal Consultant
The United States is leading the global market by capturing a share of 27% by 2033. The United States is rapidly growing by increasing pet owners, raising pet health awareness, and government initiatives. Pet owners are increasingly adopting pet diabetes care devices such as monitoring systems, syringes, and insulin pens for treating pets.
The United States pet diabetes care devices market includes key players such as Vetoquinol S.A., Zoetic Inc, IDEXX Laboratories Inc, and Merck & Co. Inc. These companies are developing and innovating technologically advanced products to satisfy end-users' demand. The United States market is estimated to expand due to increasing awareness and growing key players.
The United Kingdom is one of the significant countries that secured a CAGR of 6.30% during the forecast period. The market is growing due to the rising pet population, the prevalence of chronic diseases, and the increasing pet population. These owners are focused to monitor their pet's wellness and are increasing the adoption of pet diabetes.
Key players in the United Kingdom pet diabetes care devices market include Vetsulin, Abbott Laboratories, Medtronic, Novo Nordisk, and Zoetis Inc. These companies are implementing pet care devices with advanced technologies. The United Kingdom has well-established veterinary sectors, such as clinics and hospitals for pet care, specialized professions, and doctors. These healthcare sectors are rising in demand for pet diabetes care devices, significantly fueling the United Kingdom market.
China is registering a CAGR of 8.20% in the global market. Several factor influence China's pet diabetes care devices market are:
These crucial factors upsurge China market to another height.
India is one of the prominent leaders in the Asia Pacific that may secure a CAGR of 7.50% by 2033. India is rapidly growing by rising pet ownership and the growing pet population. Pet care devices are used to treat and monitor pets' healthcare conditions. The increasing disposable income, changing living styles, growing trends, and modernization fuel the Indian pet diabetes care devices market.
The essential players in the country are Dickinson and Company, Zoetis Inc, Novo Nordisk A/S, and Merck & Co. Inc. These players are expanding the market by innovating products with advanced technologies, distribution channels, and collaborations in the country.
The manufacturers are bringing lucrative opportunities in the market by innovating pet care products through various strategic methods. These strategies are as follows:
Manufacturers implement these strategies to provide better healthcare and management for their pet's diabetes.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market is highly competitive and presents several key players. These players are investing in research and development activities to develop new marketing strategies to develop better, affordable, unique pet care devices. The key players are adopting several marketing methodologies. Including mergers, acquisitions, product launches, collaborations, and partnerships.
Other Essential Players in the Global Market are:
Recent Developments in the Global Market are:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Countries Covered | United States, United Kingdom, Japan, India, China, Australia, Germany |
| Key Segments Covered |
|
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market will rise at a 6.2% CAGR through 2033.
By 2033, the market will reach US$ 2.3 billion.
Growing population of pets with diabetes propels market growth.
The 2023 market value is US$ 2.3 billion.
By 2033, the market will reach US$ 4.3 billion.
1. Executive Summary | Pet Diabetes Care Devices Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033 5.3.1. Cats 5.3.2. Dogs 5.3.3. Horses 5.4. Y-o-Y Growth Trend Analysis By Animal Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Device 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Device, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Device, 2023 to 2033 6.3.1. Insulin Delivery Devices 6.3.2. Insulin Delivery Pens 6.3.3. Insulin Syringes 6.3.4. Glucose Monitoring Devices 6.4. Y-o-Y Growth Trend Analysis By Device, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Device, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Veterinary Clinics 7.3.2. Home Care Settings 7.3.3. Veterinary Hospitals 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. Middle East and Africa(MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Animal Type 9.2.3. By Device 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Animal Type 9.3.3. By Device 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Animal Type 10.2.3. By Device 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Animal Type 10.3.3. By Device 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Animal Type 11.2.3. By Device 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Animal Type 11.3.3. By Device 11.3.4. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Animal Type 12.2.3. By Device 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Animal Type 12.3.3. By Device 12.3.4. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Animal Type 13.2.3. By Device 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Animal Type 13.3.3. By Device 13.3.4. By End User 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Animal Type 14.2.3. By Device 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Animal Type 14.3.3. By Device 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of Middle East and Africa(MEA) 15.2.2. By Animal Type 15.2.3. By Device 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Animal Type 15.3.3. By Device 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. The USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Animal Type 16.1.2.2. By Device 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Animal Type 16.2.2.2. By Device 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Animal Type 16.3.2.2. By Device 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Animal Type 16.4.2.2. By Device 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Animal Type 16.5.2.2. By Device 16.5.2.3. By End User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Animal Type 16.6.2.2. By Device 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Animal Type 16.7.2.2. By Device 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Animal Type 16.8.2.2. By Device 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Animal Type 16.9.2.2. By Device 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Animal Type 16.10.2.2. By Device 16.10.2.3. By End User 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Animal Type 16.11.2.2. By Device 16.11.2.3. By End User 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Animal Type 16.12.2.2. By Device 16.12.2.3. By End User 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Animal Type 16.13.2.2. By Device 16.13.2.3. By End User 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Animal Type 16.14.2.2. By Device 16.14.2.3. By End User 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Animal Type 16.15.2.2. By Device 16.15.2.3. By End User 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Animal Type 16.16.2.2. By Device 16.16.2.3. By End User 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Animal Type 16.17.2.2. By Device 16.17.2.3. By End User 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Animal Type 16.18.2.2. By Device 16.18.2.3. By End User 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Animal Type 16.19.2.2. By Device 16.19.2.3. By End User 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Animal Type 16.20.2.2. By Device 16.20.2.3. By End User 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Animal Type 16.21.2.2. By Device 16.21.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Animal Type 17.3.3. By Device 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Allison Medical 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Apotex Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Becton, Dickinson and Company 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Boehringer Ingelheim Vetmedica Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Henry Schein Animal Health 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Med Trust LLC 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Merck & Co., Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. UltiMed Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Zoetis Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. ALR Technologies Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Pet Diabetes Care Devices Market
